Search results for "Drug resistance"


 
Results 1 - 10 of about 40 for "Drug resistance".
Sort by: Relevance | Newest | Oldest

Disseminated varicella infection in an immunocompromised patient

A patient with a history of liver transplant presented with a progressive rash.
https://acphospitalist.acponline.org/archives/2024/04/03/free/disseminated-varicella-infection-in-an-immunocompromised-patient.htm
3 Apr 2024

Less definitely more in antibiotics

Review some common inpatient conditions that can be safely treated with shorter durations of antibiotics, reducing adverse events and costs.
https://acphospitalist.acponline.org/archives/2023/05/17/less-definitely-more-in-antibiotics.htm
17 May 2023

COVID-19 stalls progress made against antimicrobial resistance in U.S.

Antimicrobial-resistant infections and deaths related to hospitalization both increased by at least 15% during the first year of the pandemic, according to a recent CDC report.
https://acphospitalist.acponline.org/archives/2022/07/20/free/covid-19-stalls-progress-made-against-antimicrobial-resistance-in-us.htm
20 Jul 2022

EUAs revised for convalescent plasma, monoclonals, vaccines

In addition to the emergency use authorization (EUA) changes, recent FDA actions include a notification that some patients have had false-positive test results for syphilis after COVID-19 vaccination. The agency also approved a new antiviral to treat post-transplant cytomegalovirus infection and several newly generic drugs.
https://acphospitalist.acponline.org/archives/2022/02/02/fda-update-euas-revised-for-convalescent-plasma-monoclonals-vaccines.htm
2 Feb 2022

Malnutrition, diuretics, and more

Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/02/recent-research.htm
15 Feb 2021

IDSA releases guidance on antibiotic selection for gram-negative antimicrobial-resistant bacterial infections

New treatment guidance from the Infectious Diseases Society of America (IDSA) focused on extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
https://acphospitalist.acponline.org/weekly/archives/2020/09/16/2.htm
16 Sep 2020

Inpatient antibiotic stewardship programs decreased antibiotic use but not infection rates

Although the nine studied hospitals successfully decreased their use of targeted antibiotics, rates of extended-spectrum beta-lactamase, vancomycin-resistant enterococci, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa did not improve.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/5.htm
22 Jul 2020

Multidrug resistance

The latest edition of ICD-10 includes new codes for antibiotic resistance.
https://acphospitalist.acponline.org/archives/2020/02/coding-corner-multidrug-resistance.htm
15 Feb 2020

coding corner February 2020 • ACP Hospitalist 9 know ...

In summary, be alert to single- or multiple-drug resistance identified by culture sensitivity testing and document the type of drug resistance exhibited by the organism. ... documentation and coding. Table 3. Selected ICD-10-CM drug resistance codes. Drug Code.
https://acphospitalist.acponline.org/archives/2020/02/acph-202002-coding-corner-multidrug-resistance_t3.pdf
30 Jan 2020

coding corner 8 ACP Hospitalist • February 2020 For ...

The new drug resistance codes (category Z16) identify the antibiotics to which the infectious organism is resistant (Table 3). ... These drug resistance codes are classified as comorbidity/complications (CCs) so may change the diagnosis-related group and have a significant impact on quality metrics and reimbursement.
https://acphospitalist.acponline.org/archives/2020/02/acph-202002-coding-corner-multidrug-resistance_t2.pdf
30 Jan 2020

Result Page: Prev   1   2   3   4   Next